| Full Name | Kyle Muir |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 1007 39th Ave Se, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104231935 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 60933123 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Group Health Cooperative Home & Community Services | Seattle, WA | Hospice |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy.
A team of scientists from The Forsyth Institute, a global leader in oral health research, in collaboration with the NIH-funded Pediatric HIV/AIDS Cohort Study, has published the results of a new study indicating that differences in the mouth bacteria of youth born with HIV may increase their risk of cavities.
The Neurosciences Institute, mixed centre of the Spanish National Research Council and the Miguel Hernández University of Elche, have collaborated on the first clinical trial conducted in the world to test whether the defibrotide medicine, which has already been authorized to treat a severe obstruction of the hepatic sinusoidal veins of people who have undergone a bone marrow transplant, can be used as therapy against COVID-19.
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency accepted for review, the marketing authorization application (MAA) for anamorelin HCI, a novel, orally active selective ghrelin receptor agonist under development for the treatment of anorexia, cachexia, or unintended weight loss in non-small cell lung cancer (NSCLC) patients.
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy.
A team of scientists from The Forsyth Institute, a global leader in oral health research, in collaboration with the NIH-funded Pediatric HIV/AIDS Cohort Study, has published the results of a new study indicating that differences in the mouth bacteria of youth born with HIV may increase their risk of cavities.
The Neurosciences Institute, mixed centre of the Spanish National Research Council and the Miguel Hernández University of Elche, have collaborated on the first clinical trial conducted in the world to test whether the defibrotide medicine, which has already been authorized to treat a severe obstruction of the hepatic sinusoidal veins of people who have undergone a bone marrow transplant, can be used as therapy against COVID-19.
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency accepted for review, the marketing authorization application (MAA) for anamorelin HCI, a novel, orally active selective ghrelin receptor agonist under development for the treatment of anorexia, cachexia, or unintended weight loss in non-small cell lung cancer (NSCLC) patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Muir, 1007 39th Ave Se, Puyallup, WA 98374-2192 Ph: (253) 445-7100 | Kyle Muir, 1007 39th Ave Se, Puyallup, WA 98374 Ph: (253) 435-3100 |
News Archive
Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy.
A team of scientists from The Forsyth Institute, a global leader in oral health research, in collaboration with the NIH-funded Pediatric HIV/AIDS Cohort Study, has published the results of a new study indicating that differences in the mouth bacteria of youth born with HIV may increase their risk of cavities.
The Neurosciences Institute, mixed centre of the Spanish National Research Council and the Miguel Hernández University of Elche, have collaborated on the first clinical trial conducted in the world to test whether the defibrotide medicine, which has already been authorized to treat a severe obstruction of the hepatic sinusoidal veins of people who have undergone a bone marrow transplant, can be used as therapy against COVID-19.
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency accepted for review, the marketing authorization application (MAA) for anamorelin HCI, a novel, orally active selective ghrelin receptor agonist under development for the treatment of anorexia, cachexia, or unintended weight loss in non-small cell lung cancer (NSCLC) patients.
› Verified 4 days ago
Miao Huang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 14th Ave Se, Puyallup, WA 98372 Phone: 253-697-4000 | |
Lynn C Ostenson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 407 14th Ave Se, Puyallup, WA 98371 Phone: 253-697-4000 | |
Martin Mao-ting Lee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 702 23rd Ave Se, Puyallup, WA 98372 Phone: 253-841-4378 | |
John David Piatt, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12005 Meridian E Ste 101, Puyallup, WA 98373 Phone: 253-215-1095 Fax: 253-215-1096 | |
Seyed Abdol Reza Jalali, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2910 S Meridian Ste 350, Puyallup, WA 98373 Phone: 253-445-5750 Fax: 253-426-4142 | |
Dr. Janet Jayshree Singh, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-7655 | |
Michael Gregory Blackburn, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 15th Ave Sw Ste C, Puyallup, WA 98371 Phone: 253-841-4243 Fax: 253-864-9452 |